<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38004261</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-1729</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>26</Day></PubDate></JournalIssue><Title>Life (Basel, Switzerland)</Title><ISOAbbreviation>Life (Basel)</ISOAbbreviation></Journal><ArticleTitle>Navigating the Post-COVID-19 Immunological Era: Understanding Long COVID-19 and Immune Response.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2121</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/life13112121</ELocationID><Abstract><AbstractText>The COVID-19 pandemic has affected the world unprecedentedly, with both positive and negative impacts. COVID-19 significantly impacted the immune system, and understanding the immunological consequences of COVID-19 is essential for developing effective treatment strategies. The purpose of this review is to comprehensively explore and provide insights into the immunological aspects of long COVID-19, a phenomenon where individuals continue to experience a range of symptoms and complications, even after the acute phase of COVID-19 infection has subsided. The immune system responds to the initial infection by producing various immune cells and molecules, including antibodies, T cells, and cytokines. However, in some patients, this immune response becomes dysregulated, leading to chronic inflammation and persistent symptoms. Long COVID-19 encompasses diverse persistent symptoms affecting multiple organ systems, including the respiratory, cardiovascular, neurological, and gastrointestinal systems. In the post-COVID-19 immunological era, long COVID-19 and its impact on immune response have become a significant concern. Post-COVID-19 immune pathology, including autoimmunity and immune-mediated disorders, has also been reported in some patients. This review provides an overview of the current understanding of long COVID-19, its relationship to immunological responses, and the impact of post-COVID-19 immune pathology on patient outcomes. Additionally, the review addresses the current and potential treatments for long COVID-19, including immunomodulatory therapies, rehabilitation programs, and mental health support, all of which aim to improve the quality of life for individuals with long COVID-19. Understanding the complex interplay between the immune system and long COVID-19 is crucial for developing targeted therapeutic strategies and providing optimal care in the post-COVID-19 era.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mohan</LastName><ForeName>Aditi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Amity Institute of Biotechnology, Amity University Uttar Pradesh, Noida Sector-125, Noida 201313, Uttar Pradesh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iyer</LastName><ForeName>Venkatesh Anand</ForeName><Initials>VA</Initials><AffiliationInfo><Affiliation>Amity Institute of Biotechnology, Amity University Uttar Pradesh, Noida Sector-125, Noida 201313, Uttar Pradesh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Dharmender</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-5074-2369</Identifier><AffiliationInfo><Affiliation>Department of Biotechnology, Deenbandhu Chhotu Ram University of Science &amp;Technology, Murthal, Sonipat 131309, Haryana, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Batra</LastName><ForeName>Lalit</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-4375-9004</Identifier><AffiliationInfo><Affiliation>Regional Biocontainment Laboratory, Center for Predictive Medicine, University of Louisville, Louisville, KY 40222, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dahiya</LastName><ForeName>Praveen</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-2362-9381</Identifier><AffiliationInfo><Affiliation>Amity Institute of Biotechnology, Amity University Uttar Pradesh, Noida Sector-125, Noida 201313, Uttar Pradesh, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Life (Basel)</MedlineTA><NlmUniqueID>101580444</NlmUniqueID><ISSNLinking>2075-1729</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">autoimmunity</Keyword><Keyword MajorTopicYN="N">immune responses</Keyword><Keyword MajorTopicYN="N">inflammatory diseases</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword><Keyword MajorTopicYN="N">treatment strategies</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>25</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>25</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>25</Day><Hour>1</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38004261</ArticleId><ArticleId IdType="pmc">PMC10672162</ArticleId><ArticleId IdType="doi">10.3390/life13112121</ArticleId><ArticleId IdType="pii">life13112121</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Vabret N., Britton G.J., Gruber C., Hegde S., Kim J., Kuksin M., Levantovsky R., Malle L., Moreira A., Park M.D., et al. Immunology of COVID-19: Current state of the science. Immunity. 2020;52:910&#x2013;941. doi: 10.1016/j.immuni.2020.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.05.002</ArticleId><ArticleId IdType="pmc">PMC7200337</ArticleId><ArticleId IdType="pubmed">32505227</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X., Liu L., Shan H., Lei C.L., Hui D.S.C., et al. Clinical characteristics of Coronavirus disease 2019 in China. N. Engl. J. Med. 2020;382:1708&#x2013;1720. doi: 10.1056/NEJMoa2002032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., et al. A novel Coronavirus from patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727&#x2013;733. doi: 10.1056/NEJMoa2001017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Rumeileh S., Abdelhak A., Foschi M., Tumani H., Otto M. Guillain-Barr&#xe9; syndrome spectrum associated with COVID-19: An up-to-date systematic review of 73 cases. J. Neurol. 2021;268:1133&#x2013;1170. doi: 10.1007/s00415-020-10124-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10124-x</ArticleId><ArticleId IdType="pmc">PMC7445716</ArticleId><ArticleId IdType="pubmed">32840686</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldstein L.R., Rose E.B., Horwitz S.M., Collins J.P., Newhams M.M., Son M.B.F., Newburger J.W., Kleinman L.C., Heidemann S.M., Martin A.A., et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N. Engl. J. Med. 2020;383:334&#x2013;346. doi: 10.1056/NEJMoa2021680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021680</ArticleId><ArticleId IdType="pmc">PMC7346765</ArticleId><ArticleId IdType="pubmed">32598831</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde M.W., Kim S.S., Lindsell C.J., Billig Rose E., Shapiro N.I., Files D.C., Gibbs K.W., Erickson H.L., Steingrub J.S., Smithline H.A., et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network&#x2014;United States, March-June 2020. MMWR Morb. Mortal Wkly. Rep. 2020;69:993&#x2013;998. doi: 10.15585/mmwr.mm6930e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Sansone D., Tassinari A., Valentinotti R., Kontogiannis D., Ronchese F., Centonze S., Maggiore A., Cegolon L., Filon F.L. Persistence of Symptoms 15 Months since COVID-19 Diagnosis: Prevalence, Risk Factors and Residual Work Ability. Life. 2022;13:97. doi: 10.3390/life13010097.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life13010097</ArticleId><ArticleId IdType="pmc">PMC9862952</ArticleId><ArticleId IdType="pubmed">36676046</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortinovis M., Perico N., Remuzzi G. Long-term follow-up of recovered patients with COVID-19. Lancet. 2021;397:173&#x2013;175. doi: 10.1016/S0140-6736(21)00039-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00039-8</ArticleId><ArticleId IdType="pmc">PMC7833833</ArticleId><ArticleId IdType="pubmed">33428868</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue J.K., Franko N.M., McCulloch D.J., McDonald D., Magedson A., Wolf C.R., Chu H.Y. Sequelae in adults at 6 months after COVID-19 Infection. JAMA Netw. Open. 2021;4:e210830. doi: 10.1001/jamanetworkopen.2021.0830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V., Jayadevan R., Sashidharan S. Long COVID: An overview. Diabetes Metab. Syndr. 2021;15:869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F., Perego E. How and why patients made Long Covid. Soc. Sci. Med. 2021;268:113426. doi: 10.1016/j.socscimed.2020.113426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg M., Maralakunte M., Garg S., Dhooria S., Sehgal I., Bhalla A.S., Vijayvergiya R., Grover S., Bhatia V., Jagia P., et al. The conundrum of &#x2018;Long-COVID-19&#x2019;: A narrative review. Int. J. Gen. Med. 2021;14:2491&#x2013;2506. doi: 10.2147/IJGM.S316708.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S316708</ArticleId><ArticleId IdType="pmc">PMC8214209</ArticleId><ArticleId IdType="pubmed">34163217</ArticleId></ArticleIdList></Reference><Reference><Citation>Paces J., Strizova Z., Smrz D., Cerny J. COVID-19 and the immune system. Physiol. Res. 2020;69:379&#x2013;388. doi: 10.33549/physiolres.934492.</Citation><ArticleIdList><ArticleId IdType="doi">10.33549/physiolres.934492</ArticleId><ArticleId IdType="pmc">PMC8648321</ArticleId><ArticleId IdType="pubmed">32469225</ArticleId></ArticleIdList></Reference><Reference><Citation>Low R.N., Low R.J., Akrami A. A review of cytokine-based pathophysiology of Long COVID symptoms. Front. Med. 2023;10:1011936. doi: 10.3389/fmed.2023.1011936.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1011936</ArticleId><ArticleId IdType="pmc">PMC10103649</ArticleId><ArticleId IdType="pubmed">37064029</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleary S.J., Pitchford S.C., Amison R.T., Carrington R., Robaina Cabrera C.L., Magnen M., Looney M.R., Gray E., Page C.P. Animal models of mechanisms of SARS-CoV-2 infection and COVID-19 pathology. Br. J. Pharmacol. 2020;177:4851&#x2013;4865. doi: 10.1111/bph.15143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15143</ArticleId><ArticleId IdType="pmc">PMC7283621</ArticleId><ArticleId IdType="pubmed">32462701</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohandas S., Jagannathan P., Henrich T.J., Sherif Z.A., Bime C., Quinlan E., Portman M.A., Gennaro M., Rehman J., RECOVER Mechanistic Pathways Task Force Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC) Elife. 2023;12:e86014. doi: 10.7554/eLife.86014.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86014</ArticleId><ArticleId IdType="pmc">PMC10219649</ArticleId><ArticleId IdType="pubmed">37233729</ArticleId></ArticleIdList></Reference><Reference><Citation>Eskandarian Boroujeni M., Sekrecka A., Antonczyk A., Hassani S., Sekrecki M., Nowicka H., Lopacinska N., Olya A., Kluzek K., Wesoly J., et al. Dysregulated interferon response and immune hyperactivation in severe COVID-19: Targeting STATs as a novel therapeutic strategy. Front. Immunol. 2022;13:888897. doi: 10.3389/fimmu.2022.888897.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.888897</ArticleId><ArticleId IdType="pmc">PMC9156796</ArticleId><ArticleId IdType="pubmed">35663932</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann D.M., Boyton R.J. SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection. Sci. Immunol. 2020;5:eabd6160. doi: 10.1126/sciimmunol.abd6160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abd6160</ArticleId><ArticleId IdType="pubmed">32680954</ArticleId></ArticleIdList></Reference><Reference><Citation>Gnanaraj J., Parnes A., Francis C.W., Go R.S., Takemoto C.M., Hashmi S.K. Approach to pancytopenia: Diagnostic algorithm for clinical hematologists. Blood Rev. 2018;32:361&#x2013;367. doi: 10.1016/j.blre.2018.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.blre.2018.03.001</ArticleId><ArticleId IdType="pubmed">29555368</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky O.B., Nissen J., Cantwell L., Schwinn M., Tulstrup M., Westergaard D., Ullum H., Brunak S., Tommerup N., et al. Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients. Sci. Rep. 2021;11:13153. doi: 10.1038/s41598-021-92045-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92045-x</ArticleId><ArticleId IdType="pmc">PMC8222239</ArticleId><ArticleId IdType="pubmed">34162913</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky M.G., De Lorenzo R. Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: Role of depression and impact on quality of life. Eur. Arch. Psychiatry Clin. Neurosci. 2022;272:773&#x2013;782. doi: 10.1007/s00406-021-01346-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-021-01346-9</ArticleId><ArticleId IdType="pmc">PMC8546751</ArticleId><ArticleId IdType="pubmed">34698871</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A., Wamil M., Alberts J., Oben J., Cuthbertson D.J., Wootton D., Crooks M., Gabbay M., Brady M., Hishmeh L., et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: A prospective, community-based study. BMJ Open. 2021;11:e048391. doi: 10.1136/bmjopen-2020-048391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048391</ArticleId><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Yao Q., Gu X., Wang Q., Ren L., Wang Y., Hu P., Guo L., Liu M., Xu J., et al. 1-year outcomes in hospital survivors with COVID-19: A longitudinal cohort study. Lancet. 2021;398:747&#x2013;758. doi: 10.1016/S0140-6736(21)01755-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Munblit D., De Rose C., Sinatti D., Ricchiuto A., Carfi A., Valentini P. Preliminary evidence on long COVID in children. Acta Paediatr. 2021;110:2208&#x2013;2211. doi: 10.1111/apa.15870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15870</ArticleId><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>The Lancet Facing up to long COVID. Lancet. 2020;396:1861. doi: 10.1016/S0140-6736(20)32662-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32662-3</ArticleId><ArticleId IdType="pmc">PMC7834723</ArticleId><ArticleId IdType="pubmed">33308453</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D., Guo R., Lei L., Liu H., Wang Y., Wang Y., Qian H., Dai T., Zhang T., Lai Y., et al. Frontline science: COVID-19 infection induces readily detectable morphologic and inflammation-related phenotypic changes in peripheral blood monocytes. J. Leukoc. Biol. 2021;109:13&#x2013;22. doi: 10.1002/JLB.4HI0720-470R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.4HI0720-470R</ArticleId><ArticleId IdType="pmc">PMC7675546</ArticleId><ArticleId IdType="pubmed">33040384</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwan N.A. The road to addressing Long Covid. Science. 2021;373:491&#x2013;493. doi: 10.1126/science.abg7113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abg7113</ArticleId><ArticleId IdType="pubmed">34326224</ArticleId></ArticleIdList></Reference><Reference><Citation>Grifoni A., Weiskopf D., Ramirez S.I., Mateus J., Dan J.M., Moderbacher C.R., Rawlings S.A., Sutherland A., Premkumar L., Jadi R.S., et al. Targets of T cell responses to SARS-CoV-2 Coronavirus in humans with COVID-19 disease and unexposed individuals. Cell. 2020;181:1489&#x2013;1501.e15. doi: 10.1016/j.cell.2020.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.015</ArticleId><ArticleId IdType="pmc">PMC7237901</ArticleId><ArticleId IdType="pubmed">32473127</ArticleId></ArticleIdList></Reference><Reference><Citation>Long Q.X., Tang X.J., Shi Q.L., Li Q., Deng H.J., Yuan J., Hu J.L., Xu W., Zhang Y., Lv F.J., et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat. Med. 2020;26:1200&#x2013;1204. doi: 10.1038/s41591-020-0965-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0965-6</ArticleId><ArticleId IdType="pubmed">32555424</ArticleId></ArticleIdList></Reference><Reference><Citation>Elgellaie A., Thomas S.J., Kaelle J., Bartschi J., Larkin T. Pro-inflammatory cytokines IL-1&#x3b1;, IL-6 and TNF-&#x3b1; in major depressive disorder: Sex-specific associations with psychological symptoms. Eur. J. Neurosci. 2023;57:1913&#x2013;1928. doi: 10.1111/ejn.15992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.15992</ArticleId><ArticleId IdType="pubmed">37070163</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallais F., Velay A., Nazon C., Wendling M.J., Partisani M., Sibilia J., Candon S., Fafi-Kremer S. Intrafamilial exposure to SARS-CoV-2 associated with cellular immune response without seroconversion, France. Emerg. Infect Dis. 2021;27:113&#x2013;121. doi: 10.3201/eid2701.203611.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2701.203611</ArticleId><ArticleId IdType="pmc">PMC7774579</ArticleId><ArticleId IdType="pubmed">33261718</ArticleId></ArticleIdList></Reference><Reference><Citation>Varnait&#x117; R., Garc&#xed;a M., Glans H., Maleki K.T., Sandberg J.T., Tynell J., Christ W., Lagerqvist N., Asgeirsson H., Ljunggren H.G., et al. Expansion of SARS-CoV-2-specific antibody-secreting cells and generation of neutralizing antibodies in hospitalized COVID-19 patients. J. Immunol. 2020;205:2437&#x2013;2446. doi: 10.4049/jimmunol.2000717.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2000717</ArticleId><ArticleId IdType="pmc">PMC7576114</ArticleId><ArticleId IdType="pubmed">32878912</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechner-Scott J., Levy M., Hawkes C., Yeh A., Giovannoni G. Long COVID or post COVID-19 syndrome. Mult. Scler. Relat. Disord. 2021;55:103268. doi: 10.1016/j.msard.2021.103268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2021.103268</ArticleId><ArticleId IdType="pmc">PMC8447548</ArticleId><ArticleId IdType="pubmed">34601388</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir. Med. 2021;9:129. doi: 10.1016/S2213-2600(21)00031-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E.Y., Mao T., Klein J., Dai Y., Huck J.D., Jaycox J.R., Liu F., Zhou T., Israelow B., Wong P., et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595:283&#x2013;288. doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein S.R., Ramelli S.C., Grazioli A., Chung J.Y., Singh M., Yinda C.K., Winkler C.W., Sun J., Dickey J.M., Ylaya K., et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612:758&#x2013;763. doi: 10.1038/s41586-022-05542-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Guo C., Tang L., Hong Z., Zhou J., Dong X., Yin H., Xiao Q., Tang Y., Qu X., et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol. Hepatol. 2020;5:434&#x2013;435. doi: 10.1016/S2468-1253(20)30083-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(20)30083-2</ArticleId><ArticleId IdType="pmc">PMC7158584</ArticleId><ArticleId IdType="pubmed">32199469</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirabara S.M., Serdan T.D.A., Gorjao R., Masi L.N., Pithon-Curi T.C., Covas D.T., Curi R., Durigon E.L. SARS-CoV-2 variants: Differences and potential of immune evasion. Front. Cell. Infect Microbiol. 2022;11:781429. doi: 10.3389/fcimb.2021.781429.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.781429</ArticleId><ArticleId IdType="pmc">PMC8805732</ArticleId><ArticleId IdType="pubmed">35118007</ArticleId></ArticleIdList></Reference><Reference><Citation>Haque A., Pant A.B. Long Covid: Untangling the complex syndrome and the search for therapeutics. Viruses. 2022;15:42. doi: 10.3390/v15010042.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15010042</ArticleId><ArticleId IdType="pmc">PMC9864843</ArticleId><ArticleId IdType="pubmed">36680082</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay M.Z., Rouers A., Fong S.W., Goh Y.S., Chan Y.H., Chang Z.W., Xu W., Tan C.W., Chia W.N., Torres-Ruesta A., et al. Decreased memory B cell frequencies in COVID-19 delta variant vaccine breakthrough infection. EMBO Mol. Med. 2022;14:e15227. doi: 10.15252/emmm.202115227.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202115227</ArticleId><ArticleId IdType="pmc">PMC8899913</ArticleId><ArticleId IdType="pubmed">34994081</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J., Ding C., Li J., Wang Y., Guo H., Lu Z., Wang J., Zheng C., Jin T., Gao Y., et al. Characteristics of patients with coronavirus disease (COVID-19) confirmed using an IgM-IgG antibody test. J. Med. Virol. 2020;92:2004&#x2013;2010. doi: 10.1002/jmv.25930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25930</ArticleId><ArticleId IdType="pmc">PMC7264659</ArticleId><ArticleId IdType="pubmed">32330303</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiech M., Chroscicki P., Swatler J., Stepnik D., De Biasi S., Hampel M., Brewinska-Olchowik M., Maliszewska A., Sklinda K., Durlik M., et al. Remodeling of T cell dynamics during Long COVID is dependent on severity of SARS-CoV-2 infection. Front. Immunol. 2022;13:886431. doi: 10.3389/fimmu.2022.886431.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.886431</ArticleId><ArticleId IdType="pmc">PMC9226563</ArticleId><ArticleId IdType="pubmed">35757700</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo J., Dowell A.C., Pearce H., Verma K., Long H.M., Begum J., Aiano F., Amin-Chowdhury Z., Hoschler K., Brooks T., et al. Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection. Nat. Immunol. 2021;22:620&#x2013;626. doi: 10.1038/s41590-021-00902-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-00902-8</ArticleId><ArticleId IdType="pmc">PMC7610739</ArticleId><ArticleId IdType="pubmed">33674800</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P., Pittet L.F., Curtis N. How common is Long COVID in children and adolescents? Pediatr. Infect Dis. J. 2021;40:e482&#x2013;e487. doi: 10.1097/INF.0000000000003328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003328</ArticleId><ArticleId IdType="pmc">PMC8575095</ArticleId><ArticleId IdType="pubmed">34870392</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodda L.B., Netland J., Shehata L., Pruner K.B., Morawski P.A., Thouvenel C.D., Takehara K.K., Eggenberger J., Hemann E.A., Waterman H.R., et al. Functional SARS-CoV-2 specific immune memory persists after mild COVID-19. Cell. 2021;184:169&#x2013;183.e17. doi: 10.1016/j.cell.2020.11.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.11.029</ArticleId><ArticleId IdType="pmc">PMC7682481</ArticleId><ArticleId IdType="pubmed">33296701</ArticleId></ArticleIdList></Reference><Reference><Citation>Goel R.R., Apostolidis S.A., Painter M.M., Mathew D., Pattekar A., Kuthuru O., Gouma S., Hicks P., Meng W., Rosenfeld A.M., et al. Distinct antibody and memory B cell responses in SARS-CoV-2 na&#xef;ve and recovered individuals following mRNA vaccination. Sci. Immunol. 2021;6:eabi6950. doi: 10.1126/sciimmunol.abi6950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abi6950</ArticleId><ArticleId IdType="pmc">PMC8158969</ArticleId><ArticleId IdType="pubmed">33858945</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M., Manoharan L., Elkheir N., Cheng V., Dagens A., Hastie C., O&#x2019;Hara M., Suett J., Dahmash D., Bugaeva P., et al. Characterising long COVID: A living systematic review. BMJ Glob. Health. 2021;6:e005427. doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateus J., Grifoni A., Tarke A., Sidney J., Ramirez S.I., Dan J.M., Burger Z.C., Rawlings S.A., Smith D.M., Phillips E., et al. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Science. 2020;370:89&#x2013;94. doi: 10.1126/science.abd3871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd3871</ArticleId><ArticleId IdType="pmc">PMC7574914</ArticleId><ArticleId IdType="pubmed">32753554</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson M.G., Burgess J.L., Naleway A.L., Tyner H., Yoon S.K., Meece J., Olsho L.E.W., Caban-Martinez A.J., Fowlkes A.L., Lutrick K., et al. Prevention and attenuation of COVID-19 with the BNT162b2 and mRNA-1273 vaccines. N. Engl. J. Med. 2021;385:320&#x2013;329. doi: 10.1056/NEJMoa2107058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2107058</ArticleId><ArticleId IdType="pmc">PMC8262622</ArticleId><ArticleId IdType="pubmed">34192428</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Nemati H., Shahisavandi M., Akbari A., Emami A., Lotfi M., Rostamihosseinkhani M., Barzegar Z., Kabiri M., Zeraatpisheh Z., et al. Long COVID in children and adolescents. World J. Pediatr. 2021;17:495&#x2013;499. doi: 10.1007/s12519-021-00457-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-021-00457-6</ArticleId><ArticleId IdType="pmc">PMC8414448</ArticleId><ArticleId IdType="pubmed">34478045</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395:1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmati M., Yon D.K., Lee S.W., Udeh R., McEVoy M., Kim M.S., Gyasi R.M., Oh H., L&#xf3;pez S&#xe1;nchez G.F., Jacob L., et al. New-onset type 1 diabetes in children and adolescents as postacute sequelae of SARS-CoV-2 infection: A systematic review and meta-analysis of cohort studies. J. Med. Virol. 2023;95:e28833. doi: 10.1002/jmv.28833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28833</ArticleId><ArticleId IdType="pubmed">37264687</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Palacios-Ce&#xf1;a D., G&#xf3;mez-Mayordomo V., Cuadrado M.L., Florencio L.L. Defining post-COVID symptoms (Post-acute COVID, long COVID, persistent post-COVID): An Integrative Classification. Int. J. Environ. Res. Public Health. 2021;18:2621. doi: 10.3390/ijerph18052621.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18052621</ArticleId><ArticleId IdType="pmc">PMC7967389</ArticleId><ArticleId IdType="pubmed">33807869</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathore S., Dahiya P. Drug repurposing using computational tools and preventive strategies for COVID-19 and future pandemics. J. Health Manag. 2023;24:43&#x2013;52.</Citation></Reference><Reference><Citation>Wu L.P., Wang N.C., Chang Y.H., Tian X.Y., Na D.Y., Zhang L.Y., Zheng L., Lan T., Wang L.F., Liang G.D. Duration of antibody responses after severe acute respiratory syndrome. Emerg. Infect Dis. 2007;13:1562&#x2013;1564. doi: 10.3201/eid1310.070576.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1310.070576</ArticleId><ArticleId IdType="pmc">PMC2851497</ArticleId><ArticleId IdType="pubmed">18258008</ArticleId></ArticleIdList></Reference><Reference><Citation>Chams N., Chams S., Badran R., Shams A., Araji A., Raad M., Mukhopadhyay S., Stroberg E., Duval E.J., Barton L.M., et al. COVID-19: A multidisciplinary review. Front. Public Health. 2020;8:383. doi: 10.3389/fpubh.2020.00383.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.00383</ArticleId><ArticleId IdType="pmc">PMC7403483</ArticleId><ArticleId IdType="pubmed">32850602</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai C.K.C., Lam W. Laboratory testing for the diagnosis of COVID-19. Biochem. Biophys. Res. Commun. 2021;538:226&#x2013;230. doi: 10.1016/j.bbrc.2020.10.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.10.069</ArticleId><ArticleId IdType="pmc">PMC7598306</ArticleId><ArticleId IdType="pubmed">33139015</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers T.F., Zhao F., Huang D., Beutler N., Burns A., He W.T., Limbo O., Smith C., Song G., Woehl J., et al. Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model. Science. 2020;369:956&#x2013;963. doi: 10.1126/science.abc7520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc7520</ArticleId><ArticleId IdType="pmc">PMC7299280</ArticleId><ArticleId IdType="pubmed">32540903</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder J., Minko T. Recent developments on therapeutic and diagnostic approaches for COVID-19. AAPS J. 2021;23:14. doi: 10.1208/s12248-020-00532-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1208/s12248-020-00532-2</ArticleId><ArticleId IdType="pmc">PMC7784226</ArticleId><ArticleId IdType="pubmed">33400058</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavriatopoulou M., Ntanasis-Stathopoulos I., Korompoki E., Fotiou D., Migkou M., Tzanninis I.G., Psaltopoulou T., Kastritis E., Terpos E., Dimopoulos M.A. Emerging treatment strategies for COVID-19 infection. Clin. Exp. Med. 2021;21:167&#x2013;179. doi: 10.1007/s10238-020-00671-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-020-00671-y</ArticleId><ArticleId IdType="pmc">PMC7598940</ArticleId><ArticleId IdType="pubmed">33128197</ArticleId></ArticleIdList></Reference><Reference><Citation>Wada H., Shiraki K., Shimpo H., Shimaoka M., Iba T., Suzuki-Inoue K. Thrombotic mechanism involving platelet activation, hypercoagulability and hypofibrinolysis in coronavirus disease 2019. Int. J. Mol. Sci. 2023;24:7975. doi: 10.3390/ijms24097975.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24097975</ArticleId><ArticleId IdType="pmc">PMC10178520</ArticleId><ArticleId IdType="pubmed">37175680</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzur-Pineda K., O&#x2019;Neil C.F., Bornak A., Lalama M.J., Shao T., Kang N., Kennel-Pierre S., Tabbara M., Velazquez O.C., Rey J. COVID-19-related thrombotic complications experience before and during delta wave. J. Vasc. Surg. 2022;76:1374&#x2013;1382.e1. doi: 10.1016/j.jvs.2022.04.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2022.04.053</ArticleId><ArticleId IdType="pmc">PMC9188439</ArticleId><ArticleId IdType="pubmed">35700857</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardner A., de Mingo Pulido &#xc1;., Ruffell B. Dendritic cells and their role in immunotherapy. Front. Immunol. 2020;11:924. doi: 10.3389/fimmu.2020.00924.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00924</ArticleId><ArticleId IdType="pmc">PMC7253577</ArticleId><ArticleId IdType="pubmed">32508825</ArticleId></ArticleIdList></Reference><Reference><Citation>Morse M.A., Nair S.K., Mosca P.J., Hobeika A.C., Clay T.M., Deng Y., Boczkowski D., Proia A., Neidzwiecki D., Clavien P.A., et al. Immunotherapy with autologous, human dendritic cells transfected with carcinoembryonic antigen mRNA. Cancer Investig. 2003;21:341&#x2013;349. doi: 10.1081/CNV-120018224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1081/CNV-120018224</ArticleId><ArticleId IdType="pubmed">12901279</ArticleId></ArticleIdList></Reference><Reference><Citation>Recovery Collaborative Group. Horby P., Lim W.S., Emberson J.R., Mafham M., Bell J.L., Linsell L., Staplin N., Brightling C., Ustianowski A., et al. Dexamethasone in hospitalized patients with COVID-19. N. Engl. J. Med. 2021;384:693&#x2013;704. doi: 10.1056/NEJMoa2021436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021436</ArticleId><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Salama C., Han J., Yau L., Reiss W.G., Kramer B., Neidhart J.D., Criner G.J., Kaplan-Lewis E., Baden R., Pandit L., et al. Tocilizumab in patients hospitalized with COVID-19 pneumonia. N. Engl. J. Med. 2021;384:20&#x2013;30. doi: 10.1056/NEJMoa2030340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2030340</ArticleId><ArticleId IdType="pmc">PMC7781101</ArticleId><ArticleId IdType="pubmed">33332779</ArticleId></ArticleIdList></Reference><Reference><Citation>Carod-Artal F.J. Post-COVID-19 syndrome: Epidemiology, diagnostic criteria and pathogenic mechanisms involved. Rev. Neurol. 2021;72:384&#x2013;396. doi: 10.33588/rn.7211.2021230.</Citation><ArticleIdList><ArticleId IdType="doi">10.33588/rn.7211.2021230</ArticleId><ArticleId IdType="pubmed">34042167</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow K.W., Pham N.V., Ibrahim B.M., Hong K., Saab S. Autoimmune Hepatitis-like syndrome following COVID-19 vaccination: A systematic review of the literature. Dig. Dis. Sci. 2022;67:4574&#x2013;4580. doi: 10.1007/s10620-022-07504-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10620-022-07504-w</ArticleId><ArticleId IdType="pmc">PMC9052185</ArticleId><ArticleId IdType="pubmed">35486203</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y., Yalavarthi S., Shi H., Gockman K., Zuo M., Madison J.A., Blair C., Weber A., Barnes B.J., Egeblad M., et al. Neutrophil extracellular traps in COVID-19. JCI Insight. 2020;5:e138999. doi: 10.1172/jci.insight.138999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.138999</ArticleId><ArticleId IdType="pmc">PMC7308057</ArticleId><ArticleId IdType="pubmed">32329756</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Amelia A., Ashdown G.W., Mueller I., Coussens A.K., Eriksson E.M. Risk surveillance and mitigation: Autoantibodies as triggers and inhibitors of severe reactions to SARS-CoV-2 infection. Mol. Med. 2021;27:160. doi: 10.1186/s10020-021-00422-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-021-00422-z</ArticleId><ArticleId IdType="pmc">PMC8686808</ArticleId><ArticleId IdType="pubmed">34930107</ArticleId></ArticleIdList></Reference><Reference><Citation>Vuille-Lessard &#xc9;., Montani M., Bosch J., Semmo N. Autoimmune hepatitis triggered by SARS-CoV-2 vaccination. J. Autoimmun. 2021;123:102710. doi: 10.1016/j.jaut.2021.102710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2021.102710</ArticleId><ArticleId IdType="pmc">PMC8316013</ArticleId><ArticleId IdType="pubmed">34332438</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff M.C., Ramonell R.P., Nguyen D.C., Cashman K.S., Saini A.S., Haddad N.S., Ley A.M., Kyu S., Howell J.C., Ozturk T., et al. Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19. Nat. Immunol. 2020;21:1506&#x2013;1516. doi: 10.1038/s41590-020-00814-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-00814-z</ArticleId><ArticleId IdType="pmc">PMC7739702</ArticleId><ArticleId IdType="pubmed">33028979</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao T., Liu L., To K.K., Lim C.Y., Zhou R., Ming Y., Kwan K.Y., Yu S., Chan C.Y., Zhou B., et al. Mitochondrial regulation of acute extrafollicular B-cell responses to COVID-19 severity. Clin. Transl. Med. 2022;12:e1025. doi: 10.1002/ctm2.1025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ctm2.1025</ArticleId><ArticleId IdType="pmc">PMC9473490</ArticleId><ArticleId IdType="pubmed">36103567</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P., Rosen L.B., Zhang Q., Michailidis E., Hoffmann H.H., Zhang Y., Dorgham K., Philippot Q., Rosain J., B&#xe9;ziat V., et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370:4585. doi: 10.1126/science.abd4585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4585</ArticleId><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Meffre E., Iwasaki A. Interferon deficiency can lead to severe COVID. Nature. 2020;587:374&#x2013;376. doi: 10.1038/d41586-020-03070-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-03070-1</ArticleId><ArticleId IdType="pubmed">33139913</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia J.L., Kamceva M., Rao S.A., Linos E. Cutaneous manifestations of COVID-19: A preliminary review. J. Am. Acad. Dermatol. 2020;83:687&#x2013;690. doi: 10.1016/j.jaad.2020.05.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2020.05.059</ArticleId><ArticleId IdType="pmc">PMC7229462</ArticleId><ArticleId IdType="pubmed">32422225</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight J.S., Caricchio R., Casanova J.L., Combes A.J., Diamond B., Fox S.E., Hanauer D.A., James J.A., Kanthi Y., Ladd V., et al. The intersection of COVID-19 and autoimmunity. J. Clin. Investig. 2021;131:e154886. doi: 10.1172/JCI154886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI154886</ArticleId><ArticleId IdType="pmc">PMC8670833</ArticleId><ArticleId IdType="pubmed">34710063</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagyas M., Nagy B., Jr., R&#xe1;duly A.P., M&#xe1;nyin&#xe9; I.S., M&#xe1;rtha L., Erd&#x151;si G., Sipka S., Jr., Enyedi E., Szab&#xf3; A.&#xc1;., P&#xf3;lik Z., et al. The majority of severe COVID-19 patients develop anti-cardiac autoantibodies. Geroscience. 2022;44:2347&#x2013;2360. doi: 10.1007/s11357-022-00649-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-022-00649-6</ArticleId><ArticleId IdType="pmc">PMC9483490</ArticleId><ArticleId IdType="pubmed">36112333</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham M.W. Molecular mimicry, autoimmunity, and infection: The cross-reactive antigens of group A Streptococci and their Sequelae. Microbiol. Spectr. 2019;7 doi: 10.1128/microbiolspec.GPP3-0045-2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/microbiolspec.GPP3-0045-2018</ArticleId><ArticleId IdType="pmc">PMC6684244</ArticleId><ArticleId IdType="pubmed">31373269</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Valle D.M., Kim-Schulze S., Huang H.H., Beckmann N.D., Nirenberg S., Wang B., Lavin Y., Swartz T.H., Madduri D., Stock A., et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat. Med. 2020;26:1636&#x2013;1643. doi: 10.1038/s41591-020-1051-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1051-9</ArticleId><ArticleId IdType="pmc">PMC7869028</ArticleId><ArticleId IdType="pubmed">32839624</ArticleId></ArticleIdList></Reference><Reference><Citation>Mobasheri L., Nasirpour M.H., Masoumi E., Azarnaminy A.F., Jafari M., Esmaeili S.A. SARS-CoV-2 triggering autoimmune diseases. Cytokine. 2022;154:155873. doi: 10.1016/j.cyto.2022.155873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2022.155873</ArticleId><ArticleId IdType="pmc">PMC8979824</ArticleId><ArticleId IdType="pubmed">35461172</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahabi M., Ghazanfari T., Sepehrnia S. Molecular mimicry, hyperactive immune system, and SARS-CoV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection. Int. Immunopharmacol. 2022;112:109183. doi: 10.1016/j.intimp.2022.109183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2022.109183</ArticleId><ArticleId IdType="pmc">PMC9393178</ArticleId><ArticleId IdType="pubmed">36182877</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng M.Y., Liu W.C., Zheng J.Q., Lu C.L., Hou Y.C., Zheng C.M., Song J.Y., Lu K.C., Chao Y.C. Immunological aspects of SARS-CoV-2 infection and the putative beneficial role of Vitamin-D. Int. J. Mol. Sci. 2021;22:5251. doi: 10.3390/ijms22105251.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22105251</ArticleId><ArticleId IdType="pmc">PMC8155889</ArticleId><ArticleId IdType="pubmed">34065735</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Han T., Chen J., Hou C., Hua L., He S., Guo Y., Zhang S., Wang Y., Yuan J., et al. Clinical and autoimmune characteristics of severe and critical cases of COVID-19. Clin. Transl. Sci. 2020;13:1077&#x2013;1086. doi: 10.1111/cts.12805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cts.12805</ArticleId><ArticleId IdType="pmc">PMC7264560</ArticleId><ArticleId IdType="pubmed">32315487</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A.E., Ba D.M., Parsons N., Poudel G.R., Lekoubou A., Oh J.S., Ericson J.E., Ssentongo P., et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection. JAMA Netw. Open. 2021;4:e2128568. doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne J.A., Murthy S., Diaz J.V., Slutsky A.S., Villar J., Angus D.C., Annane D., Azevedo L.C.P., Berwanger O., Cavalcanti A.B., et al. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. JAMA. 2020;324:1330&#x2013;1341. doi: 10.1001/jama.2020.17023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.17023</ArticleId><ArticleId IdType="pmc">PMC7489434</ArticleId><ArticleId IdType="pubmed">32876694</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartone P.T., McDonald K., Hansma B.J., Solomon J. Hardiness moderates the effects of COVID-19 stress on anxiety and depression. J. Affect Disord. 2022;317:236&#x2013;244. doi: 10.1016/j.jad.2022.08.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2022.08.045</ArticleId><ArticleId IdType="pmc">PMC9398790</ArticleId><ArticleId IdType="pubmed">36028015</ArticleId></ArticleIdList></Reference><Reference><Citation>Polastri M., Nava S., Clini E., Vitacca M., Gosselink R. COVID-19 and pulmonary rehabilitation: Preparing for phase three. Eur. Respir. J. 2020;55:2001822. doi: 10.1183/13993003.01822-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01822-2020</ArticleId><ArticleId IdType="pmc">PMC7401308</ArticleId><ArticleId IdType="pubmed">32586841</ArticleId></ArticleIdList></Reference><Reference><Citation>Spruit M.A., Singh S.J., Garvey C., ZuWallack R., Nici L., Rochester C., Hill K., Holland A.E., Lareau S.C., Man W.D., et al. An official American thoracic society/European respiratory society statement: Key concepts and advances in pulmonary rehabilitation. Am. J. Respir. Crit. Care Med. 2013;188:e13&#x2013;e64. doi: 10.1164/rccm.201309-1634ST.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201309-1634ST</ArticleId><ArticleId IdType="pubmed">24127811</ArticleId></ArticleIdList></Reference><Reference><Citation>Holland A.E., Spruit M.A., Troosters T., Puhan M.A., Pepin V., Saey D., McCormack M.C., Carlin B.W., Sciurba F.C., Pitta F., et al. An official European respiratory society/American thoracic society technical standard: Field walking tests in chronic respiratory disease. Eur. Respir. J. 2014;44:1428&#x2013;1446. doi: 10.1183/09031936.00150314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00150314</ArticleId><ArticleId IdType="pubmed">25359355</ArticleId></ArticleIdList></Reference><Reference><Citation>Larson J.L., Covey M.K., Wirtz S.E. Cycle ergometer and inspiratory muscle training in chronic obstructive pulmonary disease. J. Cardiopulm. Rehabil. 2000;20:7. doi: 10.1097/00008483-200001000-00017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00008483-200001000-00017</ArticleId><ArticleId IdType="pubmed">10430720</ArticleId></ArticleIdList></Reference><Reference><Citation>Nici L., Donner C., Wouters E., Zuwallack R., Ambrosino N., Bourbeau J., Carone M., Celli B., Engelen M., Fahy B., et al. American thoracic society/European respiratory society statement on pulmonary rehabilitation. Am. J. Respir. Crit. Care Med. 2006;173:1390&#x2013;1413. doi: 10.1164/rccm.200508-1211ST.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200508-1211ST</ArticleId><ArticleId IdType="pubmed">16760357</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza M.G., De Lorenzo R., Conte C., Poletti S., Vai B., Bollettini I., Melloni E.M.T., Furlan R., Ciceri F., Rovere-Querini P., et al. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav. Immun. 2020;89:594&#x2013;600. doi: 10.1016/j.bbi.2020.07.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.07.037</ArticleId><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers J.P., Chesney E., Oliver D., Pollak T.A., McGuire P., Fusar-Poli P., Zandi M.S., Lewis G., David A.S. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: A systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7:611&#x2013;627. doi: 10.1016/S2215-0366(20)30203-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30203-0</ArticleId><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A., Trender W., Chamberlain S.R. Cognitive deficits in people who have recovered from COVID-19 relative to controls: An N=84,285 online study. medRxiv. 2021</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng K.I., Feng G., Liu W.Y., Targher G., Byrne C.D., Zheng M.H. Extrapulmonary complications of COVID-19: A multisystem disease? J. Med. Virol. 2021;93:323&#x2013;335. doi: 10.1002/jmv.26294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26294</ArticleId><ArticleId IdType="pmc">PMC7405144</ArticleId><ArticleId IdType="pubmed">32648973</ArticleId></ArticleIdList></Reference><Reference><Citation>Barker-Davies R.M., O&#x2019;Sullivan O., Senaratne K.P.P., Baker P., Cranley M., Dharm-Datta S., Ellis H., Goodall D., Gough M., Lewis S., et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br. J. Sports Med. 2020;54:949&#x2013;959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7418628</ArticleId><ArticleId IdType="pubmed">32475821</ArticleId></ArticleIdList></Reference><Reference><Citation>Negrini F., Ferrario I., Mazziotti D. Neuromuscular and balance symptoms as late effects after COVID-19: A case series. Eur. J. Phys. Rehabil. Med. 2021;57:306&#x2013;309.</Citation></Reference><Reference><Citation>Lee M.J., Sayers A.E., Drake T.M., Singh P., Bradburn M., Wilson T.R., Murugananthan A., Walsh C.J., Fearnhead N.S., NASBO Steering Group. c et al. Malnutrition, nutritional interventions and clinical outcomes of patients with acute small bowel obstruction: Results from a national, multicentre, prospective audit. BMJ Open. 2019;9:029235. doi: 10.1136/bmjopen-2019-029235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2019-029235</ArticleId><ArticleId IdType="pmc">PMC6661661</ArticleId><ArticleId IdType="pubmed">31352419</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai H.Y., Chang H.T., Lin Y.W., Huang S.H., Hsu C.Y. Nutritional intervention and the recovery of COVID-19 patients. J. Formos. Med. Assoc. 2021;120:1333&#x2013;1334.</Citation></Reference><Reference><Citation>Calder P.C., Carr A.C., Gombart A.F., Eggersdorfer M. Optimal nutritional status for a well-functioning. immune system is an important factor to protect against viral infections. Nutrients. 2020;12:1181. doi: 10.3390/nu12041181.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12041181</ArticleId><ArticleId IdType="pmc">PMC7469053</ArticleId><ArticleId IdType="pubmed">32756516</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  Water, Sanitation, Hygiene, and Waste Management for SARS-CoV-2, the Virus that Causes COVID-19. 2020.  [(accessed on 29 July 2020)].  Available online:  https://www.who.int/publications/i/item/WHO-2019-nCoV-IPC-WASH-2020.4.</Citation></Reference><Reference><Citation>Shah K., Saxena D., Mavalankar D. Secondary impact of COVID-19 on nutrition transition and food security in India. Front. Public Health. 2020;8:89699.</Citation></Reference><Reference><Citation>Ceban F., Ling S., Lui L.M.W., Lee Y., Gill H., Teopiz K.M., Rodrigues N.B., Subramaniapillai M., Di Vincenzo J.D., Cao B., et al. Fatigue and cognitive impairment in Post-COVID-19 syndrome: A systematic review and meta-analysis. Brain Behav. Immun. 2022;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Naliboff B.D., Wu S.M., Schieffer B., Bolus R., Pham Q., Baria A. A randomized trial of 2 prescription strategies for opioid-treated chronic low back pain: Results from the coordinated opioid use reduction with buprenorphine (CORB) study. Pain. 2021;162:1631&#x2013;1642. doi: 10.1097/j.pain.0000000000002193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002193</ArticleId></ArticleIdList></Reference><Reference><Citation>Chauvet-G&#xe9;linier J.C., Novella J.L., Jolly D. Impact of major depression on chronic medical illness. Encephale. 2010;36:D59&#x2013;D70.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsubaie M.M., Abbott R., Dunn B., Dickens C., Keil T.F., Henley W., Kuyken W. Mechanisms of action in mindfulness-based cognitive therapy (MBCT) and mindfulness-based stress reduction (MBSR) in people with physical and/or psychological conditions: A systematic review. Clin. Psychol. Rev. 2017;55:74&#x2013;91. doi: 10.1016/j.cpr.2017.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpr.2017.04.008</ArticleId><ArticleId IdType="pubmed">28501707</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis C.L. Peer support within a health care context: A concept analysis. Int. J. Nurs. Stud. 2003;40:321&#x2013;332. doi: 10.1016/s0020-7489(02)00092-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0020-7489(02)00092-5</ArticleId><ArticleId IdType="pubmed">12605954</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Jimenez J.L., Prather K.A., Tufekci Z., Fisman D., Schooley R. Ten scientific reasons in support of airborne transmission of SARS-CoV-2. Lancet. 2020;397:1603&#x2013;1605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8049599</ArticleId><ArticleId IdType="pubmed">33865497</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza M.G., Palladini M., De Lorenzo R., Magnaghi C., Poletti S., Furlan R., Ciceri F., Rovere-Querini P., Benedetti F., COVID-19 BioB Outpatient Clinic Study Group Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up. Brain Behav. Immun. 2020;88:105&#x2013;109. doi: 10.1016/j.bbi.2020.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>Menni C., Valdes A.M., Freidin M.B., Sudre C.H., Nguyen L.H., Drew D.A., Ganesh S., Varsavsky T., Cardoso M.J., El-Sayed Moustafa J.S., et al. Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat. Med. 2021;27:703&#x2013;709. doi: 10.1038/s41591-021-01336-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01336-3</ArticleId><ArticleId IdType="pmc">PMC7751267</ArticleId><ArticleId IdType="pubmed">32393804</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold D.T., Hamilton F.W., Milne A., Morley A.J., Viner J., Attwood M., Noel A., Gunning S., Hatrick J., Hamilton S., et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: Results from a prospective UK cohort. Thorax. 2021;76:399&#x2013;401. doi: 10.1136/thoraxjnl-2020-216086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216086</ArticleId><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang W.T., Toh H.S., Liao C.T., Yu W.L. Comprehensive review of cardiac involvement in COVID-19. Circulation. 2021;143:409&#x2013;428. doi: 10.1016/j.amjms.2020.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2020.10.002</ArticleId><ArticleId IdType="pmc">PMC7536131</ArticleId><ArticleId IdType="pubmed">33187633</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsutsui M., Gerayeli F., Sin D.D. Pulmonary Rehabilitation in a Post-COVID-19 World: Telerehabilitation as a New Standard in Patients with COPD. Int. J. Chronic Obstr. Pulm. Dis. 2021;16:379&#x2013;391. doi: 10.2147/COPD.S263031.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/COPD.S263031</ArticleId><ArticleId IdType="pmc">PMC7903963</ArticleId><ArticleId IdType="pubmed">33642858</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun T., Guo L., Tian F., Dai T., Xing X., Zhao J., Li Q. Rehabilitation in patients with COVID-19: A systematic review. J. Med. Virol. 2021;93:323&#x2013;335. doi: 10.1080/17476348.2020.1811687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17476348.2020.1811687</ArticleId><ArticleId IdType="pmc">PMC7405144</ArticleId><ArticleId IdType="pubmed">32648973</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng X., Liu Z., He X., Wang X., Yuan C., Huang L., Song R., Wu Y. Malnutrition, nutritional interventions and clinical outcomes of COVID-19: A systematic review and meta-analysis. J. Clin. Med. 2021;10:1668. doi: 10.3390/nu14245267.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14245267</ArticleId><ArticleId IdType="pmc">PMC8069968</ArticleId><ArticleId IdType="pubmed">33924667</ArticleId></ArticleIdList></Reference><Reference><Citation>Shacham M., Hamama-Raz Y., Kolerman R., Mijiritsky O., Ben-Ezra M., Mijiritsky E. Psychological and psychosocial factors associated with Long COVID-19. Int. J. Environ. Res. Public Health. 2021;18:2857. doi: 10.3390/ijerph17082900.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17082900</ArticleId><ArticleId IdType="pmc">PMC7215275</ArticleId><ArticleId IdType="pubmed">32331401</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed H., Patel K., Greenwood D.C., Halpin S., Lewthwaite P., Salawu A., Eyre L., Breen A., O&#x2019;Connor R., Jones A., et al. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis. J. Rehabil. Med. 2020;52:00063. doi: 10.2340/16501977-2694.</Citation><ArticleIdList><ArticleId IdType="doi">10.2340/16501977-2694</ArticleId><ArticleId IdType="pubmed">32449782</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham E.L., Clark J.R., Orban Z.S., Lim P.H., Szymanski A.L., Taylor C., DiBiase R.M., Jia D.T., Balabanov R., Ho S.U., et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized COVID-19 &#x201c;Long Haulers&#x201d;. Ann. Clin. Transl. Neurol. 2021;8:1073&#x2013;1085. doi: 10.1002/acn3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-month neurological and psychiatric outcomes in 236,379 survivors of COVID-19: A retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427. doi: 10.1016/S2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin S.J., McIvor C., Whyatt G., Adams A., Harvey O., McLean L., Walshaw C., Kemp S., Corrado J., Singh R., et al. Postdischarge Symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J. Med. Virol. 2021;93:1013&#x2013;1022. doi: 10.1002/jmv.26368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossen L.M., Branum A.M., Ahmad F.B., Sutton P., Anderson R.N. Excess deaths associated with COVID-19, by age and race and ethnicity&#x2014;United States. MMWR Morb. Mortal Wkly. Rep. 2020;69:1522&#x2013;1527. doi: 10.15585/mmwr.mm6942e2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6942e2</ArticleId><ArticleId IdType="pmc">PMC7583499</ArticleId><ArticleId IdType="pubmed">33090978</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dowds J., O&#x2019;Brien K., Sheill G., Dyer A.H., O&#x2019;Kelly B., Hynes J.P., Mooney A., Dunne J., Ni Cheallaigh C., et al. Persistent poor health post-COVID-19 is not associated with respiratory complications or initial disease severity. Ann. Amer. Thorac. Soc. 2021;18:997&#x2013;1003. doi: 10.1513/AnnalsATS.202009-1175OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202009-1175OC</ArticleId><ArticleId IdType="pmc">PMC8456724</ArticleId><ArticleId IdType="pubmed">33413026</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinreich D.M., Sivapalasingam S., Norton T., Ali S., Gao H., Bhore R., Musser B.J., Soo Y., Rofail D., Im J., et al. REGN-COV2, a neutralizing antibody cocktail, in outpatients with COVID-19. N. Engl. J. Med. 2021;384:238&#x2013;251. doi: 10.1056/NEJMoa2035002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2035002</ArticleId><ArticleId IdType="pmc">PMC7781102</ArticleId><ArticleId IdType="pubmed">33332778</ArticleId></ArticleIdList></Reference><Reference><Citation>Beigel J.H., Tomashek K.M., Dodd L.E., Mehta A.K., Zingman B.S., Kalil A.C., Hohmann E., Chu H.Y., Luetkemeyer A., Kline S., et al. Remdesivir for the treatment of COVID-19&#x2014;Final report. N. Engl. J. Med. 2020;383:1813&#x2013;1826. doi: 10.1056/NEJMoa2007764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2007764</ArticleId><ArticleId IdType="pmc">PMC7262788</ArticleId><ArticleId IdType="pubmed">32445440</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Gonzalez-Rojas Y., Juarez E. Early treatment for COVID-19 with SARS-CoV-2 neutralizing antibody Sotrovimab. N. Engl. J. Med. 2021;385:1941&#x2013;1950. doi: 10.1056/NEJMoa2107934.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2107934</ArticleId><ArticleId IdType="pubmed">34706189</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottlieb R.L., Nirula A., Chen P., Boscia J., Heller B., Morris J., Huhn G., Cardona J., Mocherla B., Stosor V., et al. Effect of Bamlanivimab as monotherapy or in combination with Etesevimab on viral load in patients with mild to moderate COVID-19: A randomized clinical trial. JAMA. 2021;325:632&#x2013;644. doi: 10.1001/jama.2021.0202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.0202</ArticleId><ArticleId IdType="pmc">PMC7821080</ArticleId><ArticleId IdType="pubmed">33475701</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentry C.A., Nguyen P., Thind S.K., Kurdgelashvili G., Williams R.J. Characteristics and outcomes of US Veterans at least 65 years of age at high risk of severe SARS-CoV-2 infection with or without receipt of oral antiviral agents. J. Infect. 2023;86:248&#x2013;255. doi: 10.1016/j.jinf.2023.01.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2023.01.018</ArticleId><ArticleId IdType="pmc">PMC9870610</ArticleId><ArticleId IdType="pubmed">36702309</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P., Nirula A., Heller B., Gottlieb R.L., Boscia J., Morris J., Huhn G., Cardona J., Mocherla B., Stosor V., et al. SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with COVID-19. N. Engl. J. Med. 2021;384:229&#x2013;237. doi: 10.1056/NEJMoa2029849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2029849</ArticleId><ArticleId IdType="pmc">PMC7646625</ArticleId><ArticleId IdType="pubmed">33113295</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottlieb A.B., Armstrong A.W., FitzGerald O., Gladman D.D. Prologue: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2022 Annual Meeting. J. Rheumatol. 2023:jrheum.2023-0496. doi: 10.3899/jrheum.2023-0496.</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.2023-0496</ArticleId><ArticleId IdType="pubmed">37419627</ArticleId></ArticleIdList></Reference><Reference><Citation>Camou F., Tinevez C., Beguet-Yachine M., Bellecave P., Ratiarison D., Tumiotto C., Lafarge X., Guisset O., Mourissoux G., Lafon M.E., et al. Feasibility of convalescent plasma therapy in severe COVID-19 patients with persistent SARS-CoV-2 viremia. J. Med. Virol. 2021;93:5594&#x2013;5598. doi: 10.1002/jmv.27032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27032</ArticleId><ArticleId IdType="pmc">PMC8242712</ArticleId><ArticleId IdType="pubmed">33942327</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen W., Chen C., Tang J., Wang C., Zhou M., Cheng Y., Zhou X., Wu Q., Zhang X., Feng Z., et al. Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19: A meta-analysis. Ann. Med. 2022;54:516&#x2013;523. doi: 10.1080/07853890.2022.2034936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2034936</ArticleId><ArticleId IdType="pmc">PMC8820829</ArticleId><ArticleId IdType="pubmed">35118917</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottlieb R.L., Vaca C.E., Paredes R., Mera J., Webb B.J., Perez G., Oguchi G., Ryan P., Nielsen B.U., Brown M., et al. Early Remdesivir to Prevent Progression to Severe COVID-19 in Outpatients. N. Engl. J. Med. 2022;386:305&#x2013;315. doi: 10.1056/NEJMoa2116846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2116846</ArticleId><ArticleId IdType="pmc">PMC8757570</ArticleId><ArticleId IdType="pubmed">34937145</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinner C.D., Gottlieb R.L., Criner G.J., Arribas L&#xf3;pez J.R., Cattelan A.M., Soriano Viladomiu A., Ogbuagu O., Malhotra P., Mullane K.M., Castagna A., et al. Effect of Remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: A randomized clinical trial. JAMA. 2020;324:1048&#x2013;1057. doi: 10.1001/jama.2020.16349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.16349</ArticleId><ArticleId IdType="pmc">PMC7442954</ArticleId><ArticleId IdType="pubmed">32821939</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi S., Parkar J., Ansari A., Vora A., Talwar D., Tiwaskar M., Patil S., Barkate H. Role of favipiravir in the treatment of COVID-19. Int. J. Infect Dis. 2021;102:501&#x2013;508. doi: 10.1016/j.ijid.2020.10.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.10.069</ArticleId><ArticleId IdType="pmc">PMC7831863</ArticleId><ArticleId IdType="pubmed">33130203</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhargava A., Dahiya P. COVID-19 pandemic: Assessment of current strategies and socio-economic impact. J. Health Manag. 2020;24:466&#x2013;477. doi: 10.1177/09720634221109295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09720634221109295</ArticleId></ArticleIdList></Reference><Reference><Citation>Piechotta V., Chai K.L., Valk S.J., Kimber C., Monsef I., Doree C., Wood E.M., Lamikanra A.A., Roberts D.J., McQuilten Z., et al. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: A living systematic review. Cochrane Database Syst Rev. 2020;7:CD013600. doi: 10.1002/14651858.CD013600.pub2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013600.pub2</ArticleId><ArticleId IdType="pmc">PMC7389743</ArticleId><ArticleId IdType="pubmed">32648959</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng Z., Zhu R., Hou W., Feng Y., Yang Y., Han Q., Shan G., Meng F., Du D., Wang S., et al. Transplantation of ACE2- mesenchymal stem cells improves the outcome of patients with COVID-19 Pneumonia. Aging Dis. 2020;11:216&#x2013;228. doi: 10.14336/AD.2020.0228.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2020.0228</ArticleId><ArticleId IdType="pmc">PMC7069465</ArticleId><ArticleId IdType="pubmed">32257537</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang L., Zhao J., Hu Y., Du R., Cao B. On the use of corticosteroids for 2019-nCoV pneumonia. Lancet. 2020;395:683&#x2013;684. doi: 10.1016/S0140-6736(20)30361-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30361-5</ArticleId><ArticleId IdType="pmc">PMC7159292</ArticleId><ArticleId IdType="pubmed">32122468</ArticleId></ArticleIdList></Reference><Reference><Citation>Feikin D.R., Higdon M.M., Abu-Raddad L.J., Andrews N., Araos R., Goldberg Y., Groome M.J., Huppert A., O&#x2019;Brien K.L., Smith P.G., et al. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: Results of a systematic review and meta-regression. Lancet. 2022;399:924&#x2013;944. doi: 10.1016/S0140-6736(22)00152-0. Erratum in Lancet 2023, 401, 644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00152-0</ArticleId><ArticleId IdType="pmc">PMC8863502</ArticleId><ArticleId IdType="pubmed">35202601</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Q., Chen V., Shannon C.P., Wei X.S., Xiang X., Wang X., Wang Z.H., Tebbutt S.J., Kollmann T.R., Fish E.N. Interferon-&#x3b1;2b Treatment for COVID-19. Front. Immunol. 2020;11:1061. doi: 10.3389/fimmu.2020.01061.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01061</ArticleId><ArticleId IdType="pmc">PMC7242746</ArticleId><ArticleId IdType="pubmed">32574262</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi D., Sodani M., Gupta P.K., Kulkarni S. Host directed therapies: COVID-19 and beyond. Curr. Res. Pharmacol. Drug Discov. 2021;2:100058. doi: 10.1016/j.crphar.2021.100058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.crphar.2021.100058</ArticleId><ArticleId IdType="pmc">PMC8464038</ArticleId><ArticleId IdType="pubmed">34870156</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharun K., Tiwari R., Dhama J., Dhama K. Dexamethasone to combat cytokine storm in COVID-19: Clinical trials and preliminary evidence. Int. J. Surg. 2020;82:179&#x2013;181. doi: 10.1016/j.ijsu.2020.08.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2020.08.038</ArticleId><ArticleId IdType="pmc">PMC7472975</ArticleId><ArticleId IdType="pubmed">32896649</ArticleId></ArticleIdList></Reference><Reference><Citation>Annane D. Corticosteroids for COVID-19. J. Intensive Med. 2021;1:14&#x2013;25. doi: 10.1016/j.jointm.2021.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jointm.2021.01.002</ArticleId><ArticleId IdType="pmc">PMC7919540</ArticleId><ArticleId IdType="pubmed">36943816</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasiri H., Ghazaiean M., Rouhani N., Naderi-Behdani F., Ghazaeian M., Ghodssi-Ghassemabadi R. The effects of colchicine on hospitalized COVID-19 patients: A randomized, double-blind, placebo-controlled clinical trial. J. Investig. Med. 2023;71:124&#x2013;131. doi: 10.1177/10815589221141815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10815589221141815</ArticleId><ArticleId IdType="pmc">PMC9850079</ArticleId><ArticleId IdType="pubmed">36647298</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillejos-L&#xf3;pez M., Torres-Esp&#xed;ndola L.M., Huerta-Cruz J.C., Flores-Soto E., Romero-Martinez B.S., Vel&#xe1;zquez-Cruz R., Higuera-Iglesias A., Camarena &#xc1;., Torres-Soria A.K., Salinas-Lara C., et al. Ivermectin: A Controversial Focal Point during the COVID-19 Pandemic. Life. 2022;12:1384. doi: 10.3390/life12091384.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12091384</ArticleId><ArticleId IdType="pmc">PMC9502658</ArticleId><ArticleId IdType="pubmed">36143420</ArticleId></ArticleIdList></Reference><Reference><Citation>Fact Sheet for Healthcare Providers: Emergency Use Authorization for Bebtelovimab Highlights of Emergency Use Authorization (EUA). These Highlights of the EUA Do Not Include All the Information Needed to Use Bebtelovimab under the EUA. Published on 2 May 2022.  [(accessed on 5 November 2022)]; Available online:  https://www.fda.gov/media/156152/download.</Citation></Reference><Reference><Citation>Raman B., Bluemke D.A., L&#xfc;scher T.F., Neubauer S. Long COVID: Post-acute sequelae of COVID-19 with a cardiovascular focus. Eur. Heart J. 2022;43:1157&#x2013;1172. doi: 10.1093/eurheartj/ehac031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A.K., Singh A., Singh R., Misra A. Molnupiravir in COVID-19: A systematic review of literature. Diabetes Metab. Syndr. 2021;15:102329. doi: 10.1016/j.dsx.2021.102329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.102329</ArticleId><ArticleId IdType="pmc">PMC8556684</ArticleId><ArticleId IdType="pubmed">34742052</ArticleId></ArticleIdList></Reference><Reference><Citation>Khetpal V., Berkowitz J., Vijayakumar S., Choudhary G., Mukand J.A., Rudolph J.L., Wu W.C., Erqou S. Long-term cardiovascular manifestations and complications of COVID-19: Spectrum and approach to diagnosis and management. Rhode Isl. Med. J. 2022;105:16&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">35930485</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosas I.O., Br&#xe4;u N., Waters M., Go R.C., Hunter B.D., Bhagani S., Skiest D., Aziz M.S., Cooper N., Douglas I.S., et al. Tocilizumab in hospitalized patients with severe COVID-19 Pneumonia. N. Engl. J. Med. 2021;384:1503&#x2013;1516. doi: 10.1056/NEJMoa2028700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2028700</ArticleId><ArticleId IdType="pmc">PMC7953459</ArticleId><ArticleId IdType="pubmed">33631066</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin E.J., Longo D.L., Baden L.R. Interleukin-6 receptor inhibition in COVID-19&#x2014;Cooling the inflammatory soup. N. Engl. J. Med. 2021;384:1564&#x2013;1565. doi: 10.1056/NEJMe2103108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMe2103108</ArticleId><ArticleId IdType="pmc">PMC7944949</ArticleId><ArticleId IdType="pubmed">33631064</ArticleId></ArticleIdList></Reference><Reference><Citation>Joyner M.J., Wright R.S., Fairweather D., Senefeld J.W., Bruno K.A., Klassen S.A., Carter R.E., Klompas A.M., Wiggins C.C., Shepherd J.R., et al. Early safety indicators of COVID-19 convalescent plasma in 5000 patients. J. Clin. Investig. 2020;130:4791&#x2013;4797. doi: 10.1172/JCI140200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI140200</ArticleId><ArticleId IdType="pmc">PMC7456238</ArticleId><ArticleId IdType="pubmed">32525844</ArticleId></ArticleIdList></Reference><Reference><Citation>Polack F.P., Thomas S.J., Kitchin N., Absalon J., Gurtman A., Lockhart S., Perez J.L., P&#xe9;rez Marc G., Moreira E.D., Zerbini C., et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 Vaccine. N. Engl. J. Med. 2020;383:2603&#x2013;2615. doi: 10.1056/NEJMoa2034577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2034577</ArticleId><ArticleId IdType="pmc">PMC7745181</ArticleId><ArticleId IdType="pubmed">33301246</ArticleId></ArticleIdList></Reference><Reference><Citation>Baden L.R., El Sahly H.M., Essink B., Kotloff K., Frey S., Novak R., Diemert D., Spector S.A., Rouphael N., Creech C.B., et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 Vaccine. N. Engl. J. Med. 2021;384:403&#x2013;416. doi: 10.1056/NEJMoa2035389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2035389</ArticleId><ArticleId IdType="pmc">PMC7787219</ArticleId><ArticleId IdType="pubmed">33378609</ArticleId></ArticleIdList></Reference><Reference><Citation>Haynes B.F. A new vaccine to battle COVID-19. N. Engl. J. Med. 2021;384:470&#x2013;471. doi: 10.1056/NEJMe2035557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMe2035557</ArticleId><ArticleId IdType="pmc">PMC7787216</ArticleId><ArticleId IdType="pubmed">33378607</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao K., Li J., Song H., Han H., Wang Y., Yin B., Farmer D.L., Murthy N., Wang A. In utero delivery of mRNA to the heart, diaphragm and muscle with lipid nanoparticles. Bioact. Mater. 2023;25:387&#x2013;398. doi: 10.1016/j.bioactmat.2023.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bioactmat.2023.02.011</ArticleId><ArticleId IdType="pmc">PMC9950423</ArticleId><ArticleId IdType="pubmed">36844366</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryzhikov A.B., Ryzhikov E.A., Bogryantseva M.P., Usova S.V., Nechaeva E.A., Danilenko E.D., Pyankov S.A., Gudymo A.S., Moiseeva A.A., Onkhonova G.S., et al. Assessment of safety and prophylactic efficacy of the EpiVacCorona peptide vaccine for COVID-19 prevention (Phase III) Vaccines. 2023;11:998. doi: 10.3390/vaccines11050998.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11050998</ArticleId><ArticleId IdType="pmc">PMC10222305</ArticleId><ArticleId IdType="pubmed">37243102</ArticleId></ArticleIdList></Reference><Reference><Citation>Chohan H.K., Jamal A., Mubeen M., Khan M.U., Junaid M., Chohan M.K., Imran A., Aslam A., Anwar A., Hashmi A.A., et al. The common systemic and local adverse effects of the Sinovac COVID-19 vaccine: An observational study from Pakistan. Cureus. 2023;15:e38564. doi: 10.7759/cureus.38564.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.38564</ArticleId><ArticleId IdType="pmc">PMC10239542</ArticleId><ArticleId IdType="pubmed">37284387</ArticleId></ArticleIdList></Reference><Reference><Citation>Drugs and Lactation Database (LactMed&#xae;) National Institute of Child Health and Human Development; Bethesda, MD, USA: 2023. COVID-19 Vaccines.</Citation></Reference><Reference><Citation>Longueira Y., Ojeda D.S., Battistelli R.B.A., Sanchez L., Oviedo Rouco S., Albano D., Guevara E., Valls V., Pando M.A., Gamarnik A.V. SARS-CoV-2-Specific IgG and IgA response in maternal blood and breastmilk of vaccinated na&#xef;ve and convalescent lactating participants. Front. Immunol. 2022;13:909995. doi: 10.3389/fimmu.2022.909995.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.909995</ArticleId><ArticleId IdType="pmc">PMC9574440</ArticleId><ArticleId IdType="pubmed">36263055</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthay M.A., Calfee C.S., Zhuo H., Thompson B.T., Wilson J.G., Levitt J.E., Rogers A.J., Gotts J.E., Wiener-Kronish J.P., Bajwa E.K., et al. Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): A randomised phase 2a safety trial. Lancet Respir. Med. 2019;7:154&#x2013;162. doi: 10.1016/S2213-2600(18)30418-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(18)30418-1</ArticleId><ArticleId IdType="pmc">PMC7597675</ArticleId><ArticleId IdType="pubmed">30455077</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreuzberger N., Hirsch C., Andreas M., B&#xf6;hm L., Br&#xf6;ckelmann P.J., Di Cristanziano V., Golinski M., Hausinger R.I., Mellinghoff S., Lange B., et al. Immunity after COVID-19 vaccination in people with higher risk of compromised immune status: A scoping review. Cochrane Database Syst. Rev. 2022;8:CD015021. doi: 10.1002/14651858.CD015021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD015021</ArticleId><ArticleId IdType="pmc">PMC9361430</ArticleId><ArticleId IdType="pubmed">35943061</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbott T.R., Dhamdhere G., Liu Y., Lin X., Goudy L., Zeng L., Chemparathy A., Chmura S., Heaton N.S., Debs R.P., et al. Development of CRISPR as an antiviral strategy to combat SARS-CoV-2 and influenza. Cell. 2020;181:865&#x2013;876.e12. doi: 10.1016/j.cell.2020.04.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.020</ArticleId><ArticleId IdType="pmc">PMC7189862</ArticleId><ArticleId IdType="pubmed">32353252</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Saud H., Al-Romaih K., Bakheet R., Mahmoud L., Al-Harbi N., Alshareef I., Judia S.B., Aharbi L., Alzayed A., Jabaan A., et al. Automated SARS-CoV-2 RNA extraction from patient nasopharyngeal samples using a modified DNA extraction kit for high throughput testing. Ann. Saudi Med. 2020;40:373&#x2013;381. doi: 10.5144/0256-4947.2020.373.</Citation><ArticleIdList><ArticleId IdType="doi">10.5144/0256-4947.2020.373</ArticleId><ArticleId IdType="pmc">PMC7511039</ArticleId><ArticleId IdType="pubmed">32954791</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayano&#x11f;lu F.B., El&#xe7;in A.E., El&#xe7;in Y.M. Bioethical issues in genome editing by CRISPR-Cas9 tec technology. Turk. J. Biol. 2020;44:110&#x2013;120. doi: 10.3906/biy-1912-52.</Citation><ArticleIdList><ArticleId IdType="doi">10.3906/biy-1912-52</ArticleId><ArticleId IdType="pmc">PMC7129066</ArticleId><ArticleId IdType="pubmed">32256147</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar D., Batra L., Malik M.T. Insights of Novel Coronavirus (SARS-CoV-2) disease outbreak, management and treatment. AIMS Microbiol. 2020;6:183. doi: 10.3934/microbiol.2020013.</Citation><ArticleIdList><ArticleId IdType="doi">10.3934/microbiol.2020013</ArticleId><ArticleId IdType="pmc">PMC7595841</ArticleId><ArticleId IdType="pubmed">33134740</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>